Skip to main navigation
  • About Us
    • Management Team
    • Board of Directors
  • Our Approach
    • Coronaviruses Background
    • Pipeline
    • Publications
  • Clinical Trials
  • Investors & Media
  • Partners
  • Careers
  • Contact
  • About Us
    • Management Team
    • Board of Directors
  • Our Approach
    • Coronaviruses Background
    • Pipeline
    • Publications
  • Clinical Trials
  • Investors & Media
  • Partners
  • Careers
  • Contact
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
  • Financials & Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
  • Financials & Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

SEC Filing Details

Document Details

Form
PREC14C
Filing Date
May 19, 2022
Document Date
May 19, 2022
Form Description
Preliminary information statement containing contested solicitations
Filing Group
Proxy Filings
Company
Adagio Therapeutics, Inc
Issuer
ADAGIO THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

For general inquiries:
info@adagiotx.com

For medical information
inquiries:
medinfo@adagiotx.com

781-819-0080

  • Follow
  • Follow

1601 Trapelo Road
Suite 178
Waltham, MA
02451

Privacy Policy   |   Terms of Use   |   Cookie Policy